The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor-agnostic ctDNA methylation profiling as an enabler of preoperative risk stratification and pathological response assessment in hepatocellular carcinoma.
 
Shi-Yu Zhang
No Relationships to Disclose
 
De-Zhen Guo
No Relationships to Disclose
 
Zhi-Xi Su
Employment - Singlera Genomics
 
Yi-Jun Lu
No Relationships to Disclose
 
Ao Huang
No Relationships to Disclose
 
Rui-Qing Fu
Employment - Singlera Genomics
 
Min-Jie Xu
Employment - Singlera Genomics
 
Mingyang Su
Employment - Singlera Genomics
 
Wei Li
Employment - Singlera Genomics
 
Jia Fan
No Relationships to Disclose
 
Rui Liu
Employment - Singlera Genomics
Leadership - Singlera Genomics
Stock and Other Ownership Interests - Singlera Genomics
 
Jian Zhou
Consulting or Advisory Role - AstraZeneca; MSD
Research Funding - Akeso-Sino Pharma Co., Ltd. (Inst); AstraZeneca (Inst); BeiGene (Inst); Chia Tai Tianqing Pharmaceutical Group (Inst); Eddingpharm (Suzhou) Co., Ltd. (Inst); Eisai China Inc. (Inst); Fosun Pharma (Inst); Gilead Sciences (Inst); Innovent Biologics (Inst); Jiangsu Hengrui Medicine (Inst); Junshi Biosciences (Inst); MSD (Inst); OriCell Therapeutics Co.,Ltd. (Inst); Qilu Pharmaceutical (Inst); Roche (Inst); Singlera genomics (Inst); Suzhou Zelgen Biopharmaceuticals Co., Ltd. (Inst)
 
Xin-Rong Yang
No Relationships to Disclose